SPAG9 and posterior cortical atrophy: In this study we found that DD3-ZD55-SPAG9+DTX had better effects than single treatment in inhibiting SPAG9, vimentin, and MMP-2 expressions, and promoting E-cadherin expression in PCa in vitro and in vivo.